Other
Adverse Reaction
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Adverse Reaction is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
8
clinical trials
Completed4 · 50%
Unknown status2 · 25%
Not yet recruiting1 · 13%
Enrolling by invitation1 · 13%
Clinical Trials
Trial Activity
8 trials
The Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections
Enrolling by invitation·TThe First Affiliated Hospital with Nanjing Medical University·N/A·NCT06990126·300 enrolled
Safety Evaluation of Adverse Reactions in Diabetes
Completed·—·Phase 4·NCT02092597·42 enrolled
Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction
Unknown status·—·N/A·NCT05307718·1,200 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)